0001144204-17-047782.txt : 20170913
0001144204-17-047782.hdr.sgml : 20170913
20170913082057
ACCESSION NUMBER: 0001144204-17-047782
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170913
DATE AS OF CHANGE: 20170913
EFFECTIVENESS DATE: 20170913
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Synthetic Biologics, Inc.
CENTRAL INDEX KEY: 0000894158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133808303
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-294572
FILM NUMBER: 171082251
BUSINESS ADDRESS:
STREET 1: 617 DETROIT STREET, SUITE 100
CITY: ANN ARBOR
STATE: MI
ZIP: 48104
BUSINESS PHONE: (734) 332-7800
MAIL ADDRESS:
STREET 1: 9605 MEDICAL CENTER DRIVE
STREET 2: SUITE 270
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: ADEONA PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20081027
FORMER COMPANY:
FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20061214
FORMER COMPANY:
FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19970730
D
1
primary_doc.xml
X0708
D
LIVE
0000894158
Synthetic Biologics, Inc.
9605 MEDICAL CENTER DRIVE, SUITE 270
ROCKVILLE
MD
MARYLAND
20850
(301) 417-4364
NEVADA
None
ADEONA PHARMACEUTICALS, INC.
PIPEX PHARMACEUTICALS, INC.
SHEFFIELD PHARMACEUTICALS INC
Corporation
true
Jeffrey
Riley
9605 Medical Center Drive, Suite 270
Rockville
MD
MARYLAND
20850
Executive Officer
Director
Steven
Shallcross
9605 Medical Center Drive, Suite 270
Rockville
MD
MARYLAND
20850
Executive Officer
Jeffrey
Kraws
9605 Medical Center Drive, Suite 270
Rockville
MD
MARYLAND
20850
Director
Scott
Tarriff
9605 Medical Center Drive, Suite 270
Rockville
MD
MARYLAND
20850
Director
Jeffrey
Wolf
9605 Medical Center Drive, Suite 270
Rockville
MD
MARYLAND
20850
Director
Joseph
Sliman
9605 Medical Center Drive, Suite 270
Rockville
MD
MARYLAND
20850
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2017-09-11
false
true
false
12000000
12000000
12000000
0
false
1
0
0
0
Proceeds may be used to pay overhead and other corporate expenses which could include salaries
false
Synthetic Biologics, Inc.
/s/ Steven Shallcross
Steven Shallcross
Chief Executive Officer
2017-09-13